6 research outputs found
A new benzofuran derivative from the leaves of <i>Ficus pumila</i> L.
<p>A new benzofuran derivative, pumiloside (<b>1</b>), together with seven known flavonoid glycosides, afzelin (<b>2</b>), astragalin (<b>3</b>), quercitrin (<b>4</b>), isoquercitrin (<b>5</b>), kaempferol 3-<i>O</i>-rutinoside (<b>6</b>), rutin (<b>7</b>) and kaempferol 3-<i>O</i>-sophoroside (<b>8</b>) were isolated from the leaves of <i>Ficus pumila</i>. Their structures were established by spectroscopic data and comparison with the literature values.</p
New cerebroside and chondrocyte proliferation activity of <i>Caryota mitis</i> L.
<p><i>Caryota mitis</i> L., a flowering plant, belongs to the family Arecaceae. In Vietnam, its fruits were used to treat joint pain. The present study was designed to investigate the phytochemicals and chondrocyte proliferation activity of <i>C. mitis</i> L. fruits on young human chondrocyte. The results showed that all of extracts (crude extract as well as n-hexane, chloroform, ethyl acetate and methanol fractions) were stimulated the growth of chondrocyte at 0.1 μg/mL; 0.01 μg/mL concentrations, of which the n-hexane and methanol fractions significantly increased the proliferation of chondrocyte by 30.75 and 24.42% at concentrations of 0.01 μg/mL, respectively. Repeated chromatography of the methanol fraction on silica gel, Sephadex LH-20 and ODS columns afforded a new cerebroside and eight known ones. Their structures were elucidated by analysis of spectral data and in comparison with the published reports.</p
Chemical constituents from the fruiting bodies of <i>Phellinus igniarius</i>
<p>A new tirucallane-type triterpenoid igniarine (<b>1</b>), and four known compounds meshimakobnol A (<b>2</b>), meshimakobnol B (<b>3</b>), ergosterol (<b>4</b>) and ergosterol peroxide (<b>5</b>), were purified from the methanol extracts of the fruiting bodies of <i>Phellinus igniarius</i> (DC. ex Fr.) Quél. The structure of <b>1</b> was elucidated using a combination of 1D and 2D NMR techniques and HR-ESI-MS analyses. In addition, the isolated compounds were examined for their cytotoxicity against several tumour cell lines and part of the tested compounds demonstrated weak cytotoxicity.</p
Anti-inflammatory and Antiphytopathogenic Fungal Activity of 2,3-<i>seco</i>-Tirucallane Triterpenoids Meliadubins A and B from Melia dubia Cav. Barks with ChemGPS-NP and In Silico Prediction
Two new rearranged
2,3-seco-tirucallane triterpenoids,
meliadubins A (1) and B (2), along with
four known compounds, 3–6, were isolated
from the barks of Melia dubia Cav.
Compound 2 exhibited a significant inflammatory inhibition
effect toward superoxide anion generation in human neutrophils (EC50 at 5.54 ± 0.36 μM). It bound to active sites
of a human inducible nitric oxide synthase (3E7G) through interactions
with the residues of GLU377 and PRO350, which may benefit in reducing
the neutrophilic inflammation effect. The ChemGPS-NP interpretation
combined with bioactivity assay and in silico prediction results suggested 2 to be an agent for targeting iNOS with different mechanisms
as compared to a selected set of current approved drugs. Moreover,
compounds 1 and 2 showed remarkable inhibition
against the rice pathogenic fungus Magnaporthe oryzae in a dose-dependent manner with IC50 values of 137.20
± 9.55 and 182.50 ± 18.27 μM, respectively. Both 1 and 2 displayed interactions with the residue
of TYR223, a key active site of trihydroxynaphthalene reductase (1YBV).
The interpretation of 1 and 2 in the ChemGPS-NP
physical-chemical property space indicated that both compounds are
quite different compared to all members of a selected set of reference
compounds. In light of demonstrated biological activity and in silico
prediction experiments, both compounds possibly exhibited activity
against phytopathogenic fungi via a novel mode of action
Anti-inflammatory and Antiphytopathogenic Fungal Activity of 2,3-<i>seco</i>-Tirucallane Triterpenoids Meliadubins A and B from Melia dubia Cav. Barks with ChemGPS-NP and In Silico Prediction
Two new rearranged
2,3-seco-tirucallane triterpenoids,
meliadubins A (1) and B (2), along with
four known compounds, 3–6, were isolated
from the barks of Melia dubia Cav.
Compound 2 exhibited a significant inflammatory inhibition
effect toward superoxide anion generation in human neutrophils (EC50 at 5.54 ± 0.36 μM). It bound to active sites
of a human inducible nitric oxide synthase (3E7G) through interactions
with the residues of GLU377 and PRO350, which may benefit in reducing
the neutrophilic inflammation effect. The ChemGPS-NP interpretation
combined with bioactivity assay and in silico prediction results suggested 2 to be an agent for targeting iNOS with different mechanisms
as compared to a selected set of current approved drugs. Moreover,
compounds 1 and 2 showed remarkable inhibition
against the rice pathogenic fungus Magnaporthe oryzae in a dose-dependent manner with IC50 values of 137.20
± 9.55 and 182.50 ± 18.27 μM, respectively. Both 1 and 2 displayed interactions with the residue
of TYR223, a key active site of trihydroxynaphthalene reductase (1YBV).
The interpretation of 1 and 2 in the ChemGPS-NP
physical-chemical property space indicated that both compounds are
quite different compared to all members of a selected set of reference
compounds. In light of demonstrated biological activity and in silico
prediction experiments, both compounds possibly exhibited activity
against phytopathogenic fungi via a novel mode of action
Anti-inflammatory and Antiphytopathogenic Fungal Activity of 2,3-<i>seco</i>-Tirucallane Triterpenoids Meliadubins A and B from Melia dubia Cav. Barks with ChemGPS-NP and In Silico Prediction
Two new rearranged
2,3-seco-tirucallane triterpenoids,
meliadubins A (1) and B (2), along with
four known compounds, 3–6, were isolated
from the barks of Melia dubia Cav.
Compound 2 exhibited a significant inflammatory inhibition
effect toward superoxide anion generation in human neutrophils (EC50 at 5.54 ± 0.36 μM). It bound to active sites
of a human inducible nitric oxide synthase (3E7G) through interactions
with the residues of GLU377 and PRO350, which may benefit in reducing
the neutrophilic inflammation effect. The ChemGPS-NP interpretation
combined with bioactivity assay and in silico prediction results suggested 2 to be an agent for targeting iNOS with different mechanisms
as compared to a selected set of current approved drugs. Moreover,
compounds 1 and 2 showed remarkable inhibition
against the rice pathogenic fungus Magnaporthe oryzae in a dose-dependent manner with IC50 values of 137.20
± 9.55 and 182.50 ± 18.27 μM, respectively. Both 1 and 2 displayed interactions with the residue
of TYR223, a key active site of trihydroxynaphthalene reductase (1YBV).
The interpretation of 1 and 2 in the ChemGPS-NP
physical-chemical property space indicated that both compounds are
quite different compared to all members of a selected set of reference
compounds. In light of demonstrated biological activity and in silico
prediction experiments, both compounds possibly exhibited activity
against phytopathogenic fungi via a novel mode of action